Skip to main content
icon for 海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？
政治·特朗普

海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？

icon for 海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？
政治·特朗普

海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？

最新
2026-09-30
Polymarket

$5,066 交易量

Polymarket

9月30日

$2,883 交易量

34%

10月31日

$1,479 交易量

48%

11月30日

$545 交易量

49%

12月31日

$159 交易量

56%

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump nominated physician and White House domestic policy aide Heidi Overton on August 19, 2026, to serve as FDA commissioner following Marty Makary’s May resignation. The nomination advances to the Senate for confirmation, beginning with a hearing before the HELP Committee chaired by Sen. Bill Cassidy. Cassidy immediately signaled potential opposition, citing Overton’s involvement in a recent executive order on childhood vaccines as raising significant concerns. Senate confirmation requires committee approval followed by a floor vote, where Republican majority support and any bipartisan dynamics will shape prospects amid standard nomination procedures and committee scrutiny.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
交易量
$5,066
結束日期
2027-01-01
市場開放時間
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by October 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by November 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.President Trump nominated physician and White House domestic policy aide Heidi Overton on August 19, 2026, to serve as FDA commissioner following Marty Makary’s May resignation. The nomination advances to the Senate for confirmation, beginning with a hearing before the HELP Committee chaired by Sen. Bill Cassidy. Cassidy immediately signaled potential opposition, citing Overton’s involvement in a recent executive order on childhood vaccines as raising significant concerns. Senate confirmation requires committee approval followed by a floor vote, where Republican majority support and any bipartisan dynamics will shape prospects amid standard nomination procedures and committee scrutiny.

This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.

If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”.

The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution.

The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.
交易量
$5,066
結束日期
2027-01-01
市場開放時間
Aug 20, 2026, 5:43 PM ET

Resolver

0x65070BE91...
This market will resolve to “Yes” if Heidi Overton is confirmed as Commissioner of the U.S. Food and Drug Administration by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”. If Heidi Overton's nomination is formally withdrawn, or if the Senate rejects the nomination, this market will immediately resolve to “No”. The Senate must confirm this nominee as Commissioner of the U.S. Food and Drug Administration for this market to resolve to "Yes". Recess appointments without Senate confirmation will not count toward a "Yes" resolution. The primary resolution source for this market is official information from the U.S. Senate; however, a consensus of credible reporting may also be used.

相關

icon for 馮德萊恩將於2026年卸任歐盟委員會主席？

馮德萊恩將於2026年卸任歐盟委員會主席？

4%
是
icon for 亞歷山大·奧卡西奧-科爾特斯會贏得2028年民主黨總統提名嗎？

亞歷山大·奧卡西奧-科爾特斯會贏得2028年民主黨總統提名嗎？

18%
是
icon for 國會會在2026年推翻任何否決權嗎？

國會會在2026年推翻任何否決權嗎？

7%
是

警惕外部連結哦。

Frequently Asked Questions

"海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" is a prediction market on Polymarket with 4 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "12月31日" at 56%, followed by "11月30日" at 49%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 56¢ implies that the market collectively assigns a 56% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" is a newly created market on Polymarket, launched on Aug 20, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？," browse the 4 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" is "12月31日" at 56%, meaning the market assigns a 56% chance to that outcome. The next closest outcome is "11月30日" at 49%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "海蒂·奧弗頓（ Heidi Overton ）被……證實為FDA局長？" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.